Invention Grant
- Patent Title: Compounds useful as inhibitors of ATR kinase
-
Application No.: US14723599Application Date: 2015-05-28
-
Publication No.: US09670215B2Publication Date: 2017-06-06
- Inventor: Nadia Ahmad , Jean-Damien Charrier , Chris Davis , Gorka Etxebarria I Jardi , Damien Fraysse , Ronald Knegtel , Maninder Panesar , Francoise Pierard , Joanne Pinder , Pierre-Henri Storck , John Studley
- Applicant: Vertex Pharmaceuticals Incorporated
- Applicant Address: US MA Boston
- Assignee: VERTEX PHARMACEUTICALS INCORPORATED
- Current Assignee: VERTEX PHARMACEUTICALS INCORPORATED
- Current Assignee Address: US MA Boston
- Agency: Dechert LLP
- Agent Andrea L. C. Reid
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention.The compounds of this invention have formula I-1 or I-A: wherein the variables are as defined herein.
Public/Granted literature
- US20150353560A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Public/Granted day:2015-12-10
Information query
